Comments for Wall Street reporter’s inaccurate reports are becoming patient safety issue claims biomedical company CEO at http://www.biomedreports.com , comment 1 to 13 out of 13 comments http://www.biomedreports.com Wed, 08 Feb 2012 03:20:27 +0100 FeedCreator 1.7.3 http://www.biomedreports.com/200906291683/reporters-inaccurate-articles-are-becoming-patient-safety-issue-claims-biomedical-company-ceo.html#comment-1802 I know this is a very old article, but that idiot Adam Feuerstein is at it again, this time with Adventrx Pharmaceuticals. He is a danger to patients! - justmeinnh2 Sat, 16 Jan 2010 04:18:53 +0100 http://www.biomedreports.com/200906291683/reporters-inaccurate-articles-are-becoming-patient-safety-issue-claims-biomedical-company-ceo.html#comment-513 The Street works here on biostocks. About 95% of them go south when FDA says its word. You bash them and you´re 95% right. Readers happy. Advertisers happy. You HAPPY. Some are not but does it matter; that´s always so.. - yki Fri, 17 Jul 2009 07:36:34 +0100 http://www.biomedreports.com/200906291683/reporters-inaccurate-articles-are-becoming-patient-safety-issue-claims-biomedical-company-ceo.html#comment-444 I have been personally using this stuff for over 5 years and it works great. I gargle with it when colds appeared to be coming and splashed on open cuts and wounds. Great results. - wohrlebird Wed, 01 Jul 2009 00:17:00 +0100 http://www.biomedreports.com/200906291683/reporters-inaccurate-articles-are-becoming-patient-safety-issue-claims-biomedical-company-ceo.html#comment-442 Please don't bother to read or click on AF article or even go to the street page. This will drive their rating and stock down for giving false or mislead information from factual data. - THP Tue, 30 Jun 2009 18:18:51 +0100 http://www.biomedreports.com/200906291683/reporters-inaccurate-articles-are-becoming-patient-safety-issue-claims-biomedical-company-ceo.html#comment-429 They don't short them their buddies do and the SEC says it's completely legal as long as they disclose any positions they themselves own. It's apparently well known, and they continue so... - Rob Gorgol Mon, 29 Jun 2009 11:38:30 +0100 http://www.biomedreports.com/200906291683/reporters-inaccurate-articles-are-becoming-patient-safety-issue-claims-biomedical-company-ceo.html#comment-428 Adam F is not qualified to comment or judge chemistry-based companies. Adam F has a degree in political science, not biochemistry or organic chemistry. So Adam F's attacks against biochem/biopharma companies have no merit. To prove this, have Adam F appear before a panel of experts and have him describe how the chemistry of a product, say Hemispherix Biopharma's Ampligen, works. Adam F neither understands the mechanism of operation, nor the language of the science. Yet, he bashes it. Anyone can see that Adam F is completely unqualified to make comment about the companies he attacks. Clearly then, he and his handlers have other reasons to attack, than sound scientific ones. Give you one guess what they would be. - sliderulex Mon, 29 Jun 2009 10:26:50 +0100 http://www.biomedreports.com/200906291683/reporters-inaccurate-articles-are-becoming-patient-safety-issue-claims-biomedical-company-ceo.html#comment-427 Thank you for this article exposing the real life tragedy of unethical manipulation of health care stocks. These are often new drugs & therapies that make the difference of life or death. Opinion writers are entitled to their opinions, but not entitled to spout frankly false information. Undereducated tho he may be, Feuerstein knows or ought to know that there are laws against libel and laws against interference with business. Maybe Mr Madoff would appreciate having a cellmate?! - Nancy K Mon, 29 Jun 2009 09:56:06 +0100 http://www.biomedreports.com/200906291683/reporters-inaccurate-articles-are-becoming-patient-safety-issue-claims-biomedical-company-ceo.html#comment-423 A PRODUCT THAT WORKS.TESTS,STUDIES AND DOCTORS CONFIRM THIS! COULD IT BE POSSIBLE THAT MR. F AND CRAMER COULD BE SHORT THISS STOCK? REMEMBER DAN DORFMAN USE TO SHORT A STOCK THEN WRITE IT UP NEGATIVE IN THE HEARD ON THE STREET COLUMN. TO MANY STUDIES TO MANY DOCTORS SAY IT WORKS.YOU SIMPLY COULD NOT GET SO MANY TO SAY IT WORKS TO BE ANYTHING ELSE BUT TRUE. - GEORGE DAHL Mon, 29 Jun 2009 03:35:19 +0100 http://www.biomedreports.com/200906291683/reporters-inaccurate-articles-are-becoming-patient-safety-issue-claims-biomedical-company-ceo.html#comment-422 I commend Mr. Alimi for stepping up and standing up against Feuerstein. apparently... Former Congressman Calls for Investigation of CNBC's Jim Cramer http://www.businessandmedia.org/printer/2009/20090312152514.aspx - claym711 Mon, 29 Jun 2009 02:41:15 +0100 http://www.biomedreports.com/200906291683/reporters-inaccurate-articles-are-becoming-patient-safety-issue-claims-biomedical-company-ceo.html#comment-421 THATFUCKINGASSHOLESHOULDBEFIRED. - Obbie Mon, 29 Jun 2009 02:33:00 +0100 http://www.biomedreports.com/200906291683/reporters-inaccurate-articles-are-becoming-patient-safety-issue-claims-biomedical-company-ceo.html#comment-420 I don't like F boy or what the street is doing. However, whenever you add water to chlorine you get HOCL with pH being the variable that indicates how much HOCL is formed vs the hypochorite ion (OCL-). So bleach isn't far from the truth, but how it's formulated for a specific purpose is valid. - Rob Gorgol Mon, 29 Jun 2009 02:26:57 +0100 http://www.biomedreports.com/200906291683/reporters-inaccurate-articles-are-becoming-patient-safety-issue-claims-biomedical-company-ceo.html#comment-419 I am not an expert on Chemistry and just go by recommendations of experts like Street.com authors. But, I must say, a few days back I when I researching small Bio stocks, there wasn't a single stock that street.com gave a favorable rating. I am not saying that the ratings were wrong or right (I dont know), but it looked strange - not a single company is good, though many of them are up atleast 40-50% YTD. - Asheesh Mon, 29 Jun 2009 02:04:49 +0100 http://www.biomedreports.com/200906291683/reporters-inaccurate-articles-are-becoming-patient-safety-issue-claims-biomedical-company-ceo.html#comment-418 Thank you Mr. Garza for shining light on the behavior of TheStreet, and its integrity-challenged writer. It is important that the investing community call out its bad-actors publicly and try to reduce the harm they engender. You have done a good service with this article. - JMB Mon, 29 Jun 2009 01:09:14 +0100